ST
IMGN

Spot Trading’s Immunogen Inc IMGN Stock Holding History

Spot Trading’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,184
Closed -$121K – 3922
2016
Q1 		$121K Buy
+14,184
New +$120K ﹤0.01% 2481
2015
Q2 		– Sell
-8,835
Closed -$97K – 4337
2015
Q1 		$79K Buy
+8,835
New +$64K ﹤0.01% 3171

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spot Trading's IMGN Position: Q2 2016 in Review

Spot Trading sold out of Immunogen Inc (IMGN) in Q2 2016, closing a stake of 14,184 shares — an estimated $121K sold.

Spot Trading first reported a position in IMGN in Q1 2015 and held it in 2 quarters. The position peaked at $121K in Q1 2016. 158 funds tracked by Wall St. Rank hold IMGN as of Q2 2016.

  • Spot Trading reported no remaining Immunogen Inc position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 14,184 Immunogen Inc shares in Q2 2016, an estimated $121K.
  • Spot Trading first reported a position in Immunogen Inc in Q1 2015 and held it in 2 quarters.
  • Spot Trading's Immunogen Inc position peaked at $121K in Q1 2016.
  • 158 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.